190 related articles for article (PubMed ID: 36154617)
1. Addressing the Risk of Ventricular Arrhythmias and Sudden Death in Patients With Cardiac Sarcoidosis.
Patten RD; Shah SP
Circulation; 2022 Sep; 146(13):976-979. PubMed ID: 36154617
[No Abstract] [Full Text] [Related]
2. Ventricular Arrhythmias in Cardiac Sarcoidosis.
Okada DR; Smith J; Derakhshan A; Gowani Z; Misra S; Berger RD; Calkins H; Tandri H; Chrispin J
Circulation; 2018 Sep; 138(12):1253-1264. PubMed ID: 30354431
[TBL] [Abstract][Full Text] [Related]
3. The automated implantable cardiac defibrillator. Prophylaxis in cardiac sarcoidosis.
Paz HL; McCormick DJ; Kutalek SP; Patchefsky A
Chest; 1994 Nov; 106(5):1603-7. PubMed ID: 7956431
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator.
Nordenswan HK; Pöyhönen P; Lehtonen J; Ekström K; Uusitalo V; Niemelä M; Vihinen T; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Alatalo A; Pietilä-Effati P; Kupari M
Circulation; 2022 Sep; 146(13):964-975. PubMed ID: 36000392
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis.
Iso T; Maeda D; Matsue Y; Dotare T; Sunayama T; Yoshioka K; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Minamino T
Heart; 2023 Aug; 109(18):1387-1393. PubMed ID: 37185298
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Sarcoidosis Presenting as Ventricular Tachycardia.
Simpson B; Van Hove C; Stanton C
S D Med; 2020 Aug; 73(8):356-358. PubMed ID: 32809294
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
[TBL] [Abstract][Full Text] [Related]
8. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
Skowasch D; Ringquist S; Nickenig G; Andrié R
PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
[TBL] [Abstract][Full Text] [Related]
9. Arrhythmia Monitoring and Outcomes in Patients With Cardiac Sarcoidosis: Insights From the Cardiac Sarcoidosis Consortium.
Bressi E; Crawford TC; Bogun FM; Gu X; Ellenbogen KA; Chicos AB; Roukoz H; Zimetbaum PJ; Kalbfleisch SJ; Murgatroyd FD; Steckman DA; Rosenfeld LE; Garlitski AC; Soejima K; Bhan AK; Vedantham V; Dickfeld TM; De Lurgio DB; Platonov PG; Zipse MM; Nishiuchi S; Ortman ML; Narasimhan C; Patton KK; Rosenthal DG; Mukerji SS; Hoogendoorn JC; Zeppenfeld K; Sauer WH; Kron J;
J Am Heart Assoc; 2022 Jul; 11(13):e024924. PubMed ID: 35730638
[No Abstract] [Full Text] [Related]
10. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation.
Mehta D; Mori N; Goldbarg SH; Lubitz S; Wisnivesky JP; Teirstein A
Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):43-8. PubMed ID: 21193539
[TBL] [Abstract][Full Text] [Related]
11. Long-term monitoring of arrhythmias with cardiovascular implantable electronic devices in patients with cardiac sarcoidosis.
Bakker A; Mathijssen H; Dorland G; Balt JC; van Dijk VF; Veltkamp M; Akdim F; Grutters JC; Post MC
Heart Rhythm; 2022 Mar; 19(3):352-360. PubMed ID: 34843965
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis.
Aizer A; Stern EH; Gomes JA; Teirstein AS; Eckart RE; Mehta D
Am J Cardiol; 2005 Jul; 96(2):276-82. PubMed ID: 16018857
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the 2017 AHA/ACC/HRS Guideline Recommendations for Implantable Cardioverter-Defibrillator Implantation in Cardiac Sarcoidosis.
Kazmirczak F; Chen KA; Adabag S; von Wald L; Roukoz H; Benditt DG; Okasha O; Farzaneh-Far A; Markowitz J; Nijjar PS; Velangi PS; Bhargava M; Perlman D; Duval S; Akçakaya M; Shenoy C
Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007488. PubMed ID: 31431050
[TBL] [Abstract][Full Text] [Related]
14. Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block.
Nordenswan HK; Lehtonen J; Ekström K; Kandolin R; Simonen P; Mäyränpää M; Vihinen T; Miettinen H; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Kokkonen J; Alatalo A; Pietilä-Effati P; Utriainen S; Kupari M
Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e006145. PubMed ID: 30354309
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function.
Zipse MM; Tzou WS; Schuller JL; Aleong RG; Varosy PD; Tompkins C; Borne RT; Tumolo AZ; Sandhu A; Kim D; Freeman AM; Weinberger HD; Maier LA; Sung RK; Nguyen DT; Sauer WH
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1939-1948. PubMed ID: 31257683
[TBL] [Abstract][Full Text] [Related]
16. Cardiac Sarcoidosis: A Clinical Overview.
Alba AC; Gupta S; Kugathasan L; Ha A; Ochoa A; Balter M; Sosa Liprandi A; Sosa Liprandi MI;
Curr Probl Cardiol; 2021 Oct; 46(10):100936. PubMed ID: 34400001
[TBL] [Abstract][Full Text] [Related]
17. Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator.
Mohsen A; Jimenez A; Hood RE; Dickfeld T; Saliaris A; Shorofsky S; Saba MM
J Cardiovasc Electrophysiol; 2014 Feb; 25(2):171-6. PubMed ID: 24433308
[TBL] [Abstract][Full Text] [Related]
18. Cardiac sarcoidosis with a rare initial manifestation: sustained monomorphic ventricular tachycardia.
Dhadham GC; Gupta N; Parikh R; Bikkina M
Tex Heart Inst J; 2011; 38(1):74-6. PubMed ID: 21423476
[TBL] [Abstract][Full Text] [Related]
19. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
Gowani Z; Habibi M; Okada DR; Smith J; Derakhshan A; Zimmerman SL; Misra S; Gilotra NA; Berger RD; Calkins H; Tandri H; Chrispin J
Am J Cardiol; 2020 Nov; 134():123-129. PubMed ID: 32950203
[TBL] [Abstract][Full Text] [Related]
20. Systemic sarcoidosis revealed by ventricular tachycardia: electrocardiography and MRI correspondence.
Latcu DG; Duparc A; Chabbert V; Labarre D; Mondoly P; Maury P; Delay M
Pacing Clin Electrophysiol; 2007 Dec; 30(12):1566-70. PubMed ID: 18070316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
